Acknowledgement
This work was supported by grants through funding from the Ministry of Science and Technology (MOST 108-2410-H-037-006-SS3 & MOST 111-2410-H-037-002-MY3) and Kaohsiung Veterans General Hospital (KSVGH 112-132).
References
- Mueller D, Weyler E, Gandjour A. Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis. Pharmacoeconomics 2008;26:513-536 https://doi.org/10.2165/00019053-200826060-00005
- Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet 2018;391:741-747 https://doi.org/10.1016/S0140-6736(17)32640-5
- Schousboe JT, Taylor BC, Fink HA, Kane RL, Cummings SR, Orwoll ES, et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 2007;298:629-637 https://doi.org/10.1001/jama.298.6.629
- Ito K. Cost-effectiveness of screening for osteoporosis in older men with a history of falls. JAMA Netw Open 2020;3:e2027584
- Yoshimura M, Moriwaki K, Noto S, Takiguchi T. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women. Osteoporos Int 2017;28:643-652 https://doi.org/10.1007/s00198-016-3782-5
- Nayak S, Roberts MS, Greenspan SL. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann Intern Med 2011;155:751-761 https://doi.org/10.7326/0003-4819-155-11-201112060-00007
- Turner DA, Khioe RFS, Shepstone L, Lenaghan E, Cooper C, Gittoes N, et al. The cost-effectiveness of screening in the community to reduce osteoporotic fractures in older women in the UK: economic evaluation of the SCOOP study. J Bone Miner Res 2018;33:845-851 https://doi.org/10.1002/jbmr.3381
- Chan DC, McCloskey EV, Chang CB, Lin KP, Lim LC, Tsai KS, et al. Establishing and evaluating FRAX(R) probability thresholds in Taiwan. J Formos Med Assoc 2017;116:161-168 https://doi.org/10.1016/j.jfma.2016.03.006
- Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press, 2015
- Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009;28:3083-3107 https://doi.org/10.1002/sim.3697
- Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 2015;34:3661-3679 https://doi.org/10.1002/sim.6607
- Schacht A, Bogaerts K, Bluhmki E, Lesaffre E. A new nonparametric approach for baseline covariate adjustment for two-group comparative studies. Biometrics 2008;64:1110-1116 https://doi.org/10.1111/j.1541-0420.2008.00994.x
- Federspiel JJ, Anstrom KJ, Xian Y, McCoy LA, Effron MB, Faries DE, et al. Comparing inverse probability of treatment weighting and instrumental variable methods for the evaluation of adenosine diphosphate receptor inhibitors after percutaneous coronary intervention. JAMA Cardiol 2016;1:655-665 https://doi.org/10.1001/jamacardio.2016.1783
- Hong GS, Lee CW, Lee JH, Kim B, Lee JB. Clinical impact of a quality improvement program including dedicated emergency radiology personnel on emergency surgical management: a propensity score-matching study. Korean J Radiol 2022;23:878-888 https://doi.org/10.3348/kjr.2022.0278
- Wang CY, Fu SH, Hung CC, Yang RS, Lin JW, Chen HM, et al. Impact of the requirement of bone mineral density evidence on utilization of anti-osteoporosis medications, clinical outcome and medical expenditures of patient with hip fracture in Taiwan. Int J Health Policy Manag 2022;11:470-478
- Abrahamsen B, Osmond C, Cooper C. Life expectancy in patients treated for osteoporosis: observational cohort study using national Danish prescription data. J Bone Miner Res 2015;30:1553-1559 https://doi.org/10.1002/jbmr.2478
- Bliuc D, Tran T, van Geel T, Adachi JD, Berger C, van den Bergh J, et al. Mortality risk reduction differs according to bisphosphonate class: a 15-year observational study. Osteoporos Int 2019;30:817-828 https://doi.org/10.1007/s00198-018-4806-0
- Chen JL, Tai TW, Chou CY, Ku CK, Chien LN, Huang TW, et al. Incidence of different types of subsequent fractures and related mortality in Taiwan. Arch Osteoporos 2022;17:55
- Soong YK, Tsai KS, Huang HY, Yang RS, Chen JF, Wu PC, et al. Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan. Osteoporos Int 2013;24:511-521 https://doi.org/10.1007/s00198-012-1984-z
- Guzon-Illescas O, Perez Fernandez E, Crespi Villarias N, Quiros Donate FJ, Pena M, Alonso-Blas C, et al. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res 2019;14:203
- Lee TC, Ho PS, Lin HT, Ho ML, Huang HT, Chang JK. One-year readmission risk and mortality after hip fracture surgery: a national population-based study in Taiwan. Aging Dis 2017;8:402-409 https://doi.org/10.14336/AD.2016.1228
- Ministry of Health and Welfare. Analysis of statistical results of death causes in 2020 Taiwan (R.O.C.), 2019 [accessed on June 16, 2023]. Available at: https://www.mohw.gov.tw/np-126-2.html
- World Health Organization. World health statistics 2021: monitoring health for the SDGs, sustainable development goals [accessed on May 20, 2021]. Available at: https://www.who.int/publications/i/item/9789240027053
- Ho-Le TP, Tran TS, Bliuc D, Pham HM, Frost SA, Center JR, et al. Epidemiological transition to mortality and refracture following an initial fracture. Elife 2021;10:e61142
- Mobley LR, Hoerger TJ, Wittenborn JS, Galuska DA, Rao JK. Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate. Med Decis Making 2006;26:194-206 https://doi.org/10.1177/0272989X06286478
- Si L, Winzenberg TM, Chen M, Jiang Q, Neil A, Palmer AJ. Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study. Osteoporos Int 2016;27:2259-2269 https://doi.org/10.1007/s00198-016-3502-1
- Su Y, Lai FTT, Yip BHK, Leung JCS, Kwok TCY. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong. Osteoporos Int 2018;29:1793-1805 https://doi.org/10.1007/s00198-018-4543-4
- Merlijn T, Swart KM, van Schoor NM, Heymans MW, van der Zwaard BC, van der Heijden AA, et al. The effect of a screening and treatment program for the prevention of fractures in older women: a randomized pragmatic trial. J Bone Miner Res 2019;34:1993-2000 https://doi.org/10.1002/jbmr.3815
- Cornelissen D, de Kunder S, Si L, Reginster JY, Evers S, Boonen A, et al. Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 2020;31:1645-1669 https://doi.org/10.1007/s00198-020-05378-0
- Pisu M, Kopperdahl DL, Lewis CE, Saag KG, Keaveny TM. Cost-effectiveness of osteoporosis screening using biomechanical computed tomography for patients with a previous abdominal CT. J Bone Miner Res 2019;34:1229-1239 https://doi.org/10.1002/jbmr.3700
- Song YS, Lee WW, Park MS, Kim NT, Sung KH. Usefulness of bone SPECT/CT for predicting avascular necrosis of the femoral head in children with slipped capital femoral epiphysis or femoral neck fracture. Korean J Radiol 2022;23:264-270 https://doi.org/10.3348/kjr.2021.0545
- Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005
- Lee HY, Hung MC, Hu FC, Chang YY, Hsieh CL, Wang JD. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan. J Formos Med Assoc 2013;112:699-706 https://doi.org/10.1016/j.jfma.2012.12.015
- Kung AW, Fan T, Xu L, Xia WB, Park IH, Kim HS, et al. Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study. BMC Womens Health 2013;13:7
- Soreskog E, Borgstrom F, Shepstone L, Clarke S, Cooper C, Harvey I, et al. Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Osteoporos Int 2020;31:1499-1506 https://doi.org/10.1007/s00198-020-05372-6
- Ramachandran S, Williams SA, Weiss RJ, Wang Y, Zhang Y, Nsiah I, et al. Gender disparities in osteoporosis screening and management among older adults. Adv Ther 2021;38:3872-3887 https://doi.org/10.1007/s12325-021-01792-w